Skye Bioscience, Inc. (SKYE)

CIK 1516551 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Skye Bioscience, Inc..

Recent SEC filings

FiledFormAccession number
Oct 28, 2026PRER14A0001628280-26-067744
Oct 26, 2026PREM14A0001628280-26-067322
Oct 14, 2026SCHEDULE 13G0001214659-26-012924
Sep 24, 202640001231919-26-001224
Sep 24, 2026SCHEDULE 13D/A0001873545-26-000009
Sep 24, 202640001598549-26-000015
Sep 18, 202640001598549-26-000013
Sep 18, 202640001231919-26-001197
Sep 11, 20268-K0001628280-26-061558
Sep 11, 2026DEFA14A0001628280-26-061564
Aug 24, 2026DEFA14A0001628280-26-058615
Aug 24, 20268-K0001628280-26-058605
Aug 20, 202640001231919-26-000959
Aug 20, 2026DEFA14A0001628280-26-058121
Aug 20, 202640001598549-26-000005
Aug 20, 20268-K/A0001628280-26-058120
Aug 19, 2026DEFA14A0001628280-26-057806
Aug 19, 20268-K0001628280-26-057804
Aug 18, 2026SCHEDULE 13D/A0001873545-26-000007
Aug 14, 20268-K0001628280-26-056966
Aug 14, 202610-Q0001628280-26-056968
Aug 14, 2026DEFA14A0001628280-26-056979
Aug 7, 202640001628280-26-054941
Jun 23, 20268-K0001628280-26-044747
May 29, 20268-K0001628280-26-039233